Partial exit of significant holding

RNS Number : 9819Z
F&C Private Equity Trust PLC
06 September 2018
 

To: Stock Exchange

For immediate release:


6 September 2018

 

F&C Private Equity Trust plc

LEI: 2138009FW98WZFCGRN66

 

Partial Exit of significant holding - Ambio

 

F&C Private Equity Trust PLC announces that 75% of its holding in Ambio Holdings Inc, the South Carolina based manufacturer of peptide based active pharmaceutical ingredient and developer of generic pharmaceuticals, has been realised through the sale to the Asian arm of a large international private equity firm. The net proceeds to F&C Private Equity are £17.6m, representing  3.75x cost. F&C  Private Equity Trust retains 25% of its holding  which is valued at £5.8m. The combined value of the  proceeds and the retained component, at the acquisition value, represents a net 5.0x cost and an IRR of 52%. The associated uplift in valuation resulting from this transaction is £5.7m, equivalent to approximately 2.2% of the Company's NAV. This investment ,which was led by MVM Partners, has made excellent fundamental progress since investment in October 2014 with Revenue growing from $16.3m to $52.9m and EBITDA from $3.1m to $16.7m.

 

 

 

 

 

For more information, please contact:

 

Hamish Mair (Fund Manager)

0131 718 1184

hamish.mair@bmogam.com

 

Scott McEllen (Company Secretary)

 

0131 718 1137

scott.mcellen@bmogam.com

 

 

 

 

 

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PFUVQLBBVKFZBBV
UK 100

Latest directors dealings